SPAC熱潮再起！+創新T細胞療法公司Estrella上市+估值近4億美元 - 環球生技月刊

website2646

Oct 5, 2022

1 min read

Recent Posts

https://ir.bhtherapeutics.com/news-releases/news-release-details/blossomhill-therapeutics-announces-pricing-upsized-150-million

https://alamarbio.com/alamar-biosciences-announces-pricing-of-upsized-initial-public-offering/

https://www.businesswire.com/news/home/20250122706462/en/BlossomHill-Therapeutics-Doses-Patients-in-the-First-Cohort-of-the-Phase-12-SOLA...